TP53 and colorectal carcinoma: Human colorectal carcinoma cells, HCT116, show β-HB-mediated p53 Kbhb at the K120, K319, and K370 sites, which leads to lower levels of p53 acetylation and consequently decreased activity, causing weakened tumour-suppressive functions [154].